A leading mid sized European pharmaceutical company, with interests across multiple therapeutic areas.

With impending multiple drug launches over the next few years, the new leadership helming pharmacovigilance wanted to create a business case for a 3-year transformation roadmap for future readiness to
Business case was to be created keeping in mind the organization’s current systems and processes and taking a practical approach with incremental change
We established a programmatic evaluation process for the changing competitive landscape. The client was able to achieve consensus and confidence amongst internal stakeholders, on the launch plan. The product launch plan was used to target the competitive environment differently.